Faculty Disclosures
|
No disclosure on file
|
| Joseph C. Masdeu, MD, PhD, FAAN |
Dr. Masdeu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Moody Foundation. The institution of Dr. Masdeu has received research support from Biogen. The institution of Dr. Masdeu has received research support from Eli Lilly. The institution of Dr. Masdeu has received research support from Eisai. The institution of Dr. Masdeu has received research support from Novartis. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE. |
| Daniel R. Weinberger, MD |
No disclosure on file
|
| Paul J. Spira, MD, MB, BS |
No disclosure on file
|
| Alain Creange |
No disclosure on file
|
| Roy G. Beran, MD, FAAN |
Dr. Beran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Beran has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Esai. Dr. Beran has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for somnomed. Dr. Beran has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for CMC Lawyers. Dr. Beran has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Bannisters Lawyers. Dr. Beran has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Victorian Crown prosecution. Dr. Beran has received publishing royalties from a publication relating to health care. Dr. Beran has received publishing royalties from a publication relating to health care. |
| Mark Lawden, MD |
No disclosure on file
|
| Carl E. Clarke |
No disclosure on file
|
| Alexandra J. Sinclair, MD |
Dr. Sinclair has received personal compensation for serving as an employee of Invex Therapeutics. Dr. Sinclair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Sinclair has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion Pharma. Dr. Sinclair has stock in Invex Therapeutics (unclear what the company is developing but no longer working in the field of Idiopathic Intracranial Hypertension). The institution of Dr. Sinclair has received research support from DOD. The institution of Dr. Sinclair has received research support from MOD. |
| Asimina Athanasouli |
Asimina Athanasouli has nothing to disclose. |
| Victoria Smith |
No disclosure on file
|
| Elliott Ridgeon |
No disclosure on file
|